U.S. Biotech Stock News

United Therapeutics (UTHR) recently drew investor attention with its landmark clinical xenotransplantation announcement in the EXPAND study, while its stock also responded to a mixed quarter of earnings and sizeable pre-arranged insider sales. See our latest analysis for United Therapeutics. Following the headline-making xenotransplant news and recent insider sales, United Therapeutics’ share price has surged, jumping nearly 49% over the past three months. The company has also posted a 1-year...

Vita Coco Company (COCO) recently adjusted its supply chain to reduce the impact of U.S. tariffs by moving production across seven countries. The business is also expanding in the U.K. and Germany, leading to an improved full-year sales outlook. See our latest analysis for Vita Coco Company. The company’s nimble response to tariffs and its expansion into new European markets have coincided with building investor momentum. This is reflected by a 9.8% one-month share price return and a standout...

Penumbra (PEN) has caught investors’ attention lately, with shares up about 11% over the past month and 18% for the past year. The company’s consistent gains reflect market confidence in its growth trajectory. See our latest analysis for Penumbra. Penumbra’s 17.8% total return over the past year signals real momentum, with the current share price gaining 10.9% in just the last month. Strong quarterly updates have kept optimism high, as investors continue to see upside in medical device...

Earlier this month, AbCellera Biologics announced the appointment of renowned scientist and entrepreneur Dr. Stephen Quake as an independent director, the departure of board member Dr. Andrew W. Lo, and the upcoming exit of SVP of Development Dr. Geoff Nichol, alongside reporting third-quarter 2025 earnings showing revenue growth to US$8.96 million with net losses widening to US$57.12 million. Dr. Quake’s extensive scientific, academic, and entrepreneurial background, recently recognized by...

Gorman-Rupp (GRC) recently reported quarterly results that showed revenues increased compared to last year, although both earnings and revenue missed expectations. In addition to these results, the company announced facility closures and a broader shift in its operational focus. See our latest analysis for Gorman-Rupp. Following the earnings miss and facility closures, Gorman-Rupp's stock stumbled, falling 8.7% after results. Still, momentum has been picking up. Its year-to-date share price...

Incyte (INCY) recently reported impressive third quarter results, with strong revenue growth that surpassed expectations. The earnings release drew a positive reaction from investors as excitement builds around the company's expanding oncology pipeline and upcoming milestones. See our latest analysis for Incyte. Momentum has clearly accelerated for Incyte, with a 30-day share price return of 18.15% and a total return of 49.79% year-to-date. This underscores how strong earnings and promising...

PJT Partners reported a strong set of third-quarter and nine-month results, with revenue reaching US$447.09 million and net income at US$39.84 million for the third quarter ended September 30, 2025, both up compared to the previous year. Alongside the earnings, the company declared a US$0.25 per share dividend and provided an update that no shares were repurchased this quarter under its ongoing buyback program. We'll examine how PJT Partners’ income growth and continued dividend payments...

Terex Corporation recently presented at the 18th Annual New York Global Innovation Summit at The Yale Club, with Senior VP & Chief Digital Officer David Jutcawitz as a featured speaker. This event coincided with renewed analyst confidence in Terex, linking improved business mix and sector momentum to an enhanced earnings outlook. We'll examine how analyst optimism, supported by trends in digital innovation and heavy equipment demand, could affect Terex's investment narrative. AI is about to...

Xometry, Inc. raised its full-year 2025 revenue guidance to a range of US$676 million to US$678 million, and for the fourth quarter, projected revenues of US$182 million to US$184 million, following third-quarter results showing sales of US$180.72 million, up from US$141.7 million a year earlier. The company's improved outlook comes after sustained revenue growth, highlighting ongoing demand for its AI-powered manufacturing marketplace despite continuing net losses. We'll explore how...

Zillow Group (ZG) shares have dropped about 2% today after the company reported annual net income figures that showed a loss of $32 million, even though revenue climbed over the past year. Investors are considering what this means for Zillow’s ongoing shift in the real estate technology space. See our latest analysis for Zillow Group. While today’s dip follows weaker-than-expected profitability, it’s the broader trend that stands out: Zillow’s share price is now down 4.1% for the year-to-date...

Barclays initiated coverage on Penske Automotive Group (PAG) with an Overweight rating on November 12. This caught the eye of investors and sparked new interest in the stock’s outlook. See our latest analysis for Penske Automotive Group. Penske Automotive Group’s share price has seen some ups and downs over the past few months, with a recent 6.97% dip over 30 days but a solid year-to-date gain of nearly 6%. Despite some short-term volatility, the company’s long-term momentum remains...

On November 12, 2025, Cleveland-Cliffs Inc. appointed Edilson Camara, former CEO of Egon Zehnder, to its Board of Directors, placing him on the Compensation and Organization Committee. Camara’s expertise in executive assessment, talent management, and capital-intensive global industries could bring fresh perspectives to Cleveland-Cliffs’ governance and long-term industrial transformation. With Camara’s background guiding global industrial firms, we’ll explore how his addition may influence...

Intel (INTC) shares have seen some movement recently, prompting a closer look at how the stock is performing this month as well as over the past 3 months. Investors are weighing broader sector trends in addition to company-specific factors as they consider next steps. See our latest analysis for Intel. Despite a recent dip, Intel's share price has shown impressive longer-term momentum, with a 44.6% gain over the past three months and a 75.7% share price return year-to-date. The latest 1-year...

GCI Liberty (GLIB.A) has seen its stock edge slightly lower over the past month, catching the attention of investors interested in its valuation and performance trends. Recent moves may reflect shifting market sentiment. See our latest analysis for GCI Liberty. GCI Liberty's 30-day share price return of -11.5% stands out, especially after its steadier start to the year. The momentum has recently faded rather than built. Despite earlier stability, the latest movement signals that investors may...

Mr. Cooper Group (COOP) drew attention after investor David Nierenberg cut his position in the company by 57%, selling over 169,000 shares. Moves like this from prominent shareholders often cause investors to wonder what could come next for the stock. See our latest analysis for Mr. Cooper Group. It’s been quite a ride for Mr. Cooper Group this year. After a remarkable stretch, including a 15.6% 1-month share price return and an eye-popping 132.4% total shareholder return over the past 12...

Pure Storage (PSTG) shares are showing resilience, climbing just under 1% today despite a fairly quiet news cycle. Investors seem to be weighing the company’s long-term growth story and recent performance in a broader tech context. See our latest analysis for Pure Storage. While Pure Storage’s share price has pulled back about 8.6% over the past month, the stock’s latest 1-day gain adds to what has been a strong stretch. Momentum remains very much intact, with total shareholder returns...

Wondering if Firefly Aerospace is a bargain or overpriced right now? You are not alone, as curiosity around the stock's real value is picking up steam. After a rocky start to the year, the stock surged 16.3% in the last week. This comes after a steep 62.0% slide year-to-date and a recent 22.5% drop over the past month. This comeback follows reports that Firefly recently secured additional contracts in the commercial launch sector, alongside growing investor attention as the...

Dollar General (DG) shares have shown a modest move over the past week, with the stock edging slightly higher. The market seems to be weighing the retailer’s fundamentals in comparison with recent trends in consumer spending. See our latest analysis for Dollar General. After a quiet stretch, Dollar General’s share price has seen fresh momentum, gaining over 5% for a 7-day share price return. Despite lingering headwinds from the past few years, the 1-year total shareholder return now stands at...

Earlier this week, Precigen announced it received full FDA approval and launched Papzimeos in the US as the first and only available therapy for adults with recurrent respiratory papillomatosis, rapidly engaging over 90% of target institutions and registering more than 100 patients to date. This significant regulatory achievement marks Precigen’s shift from a development-stage to a commercial-stage biopharmaceutical company, opening new revenue streams but also highlighting its financial...

Lindsay (LNN) has seen its stock move lower in recent trading, catching the eye of investors who are wondering what may be driving this trend. Over the past month, shares have declined by 18%. See our latest analysis for Lindsay. While Lindsay’s 1-day and 7-day share price returns show only mild movement, the real story is the sharp 18.1% drop in the past month. This has added to a year-to-date decline and brought the total shareholder return for the past year down to -9.7%. Although recent...

UiPath (PATH) caught the attention of investors this week after experiencing modest shifts in its share price. With the stock showing a dip over the past month but gains in the past 3 months, many are taking a closer look at what is driving these movements. See our latest analysis for UiPath. UiPath’s share price swung lower over the last month but remains well above its spring lows. A 28% gain over the past three months signals renewed investor interest. Looking over the past year, the 13.4%...

Protagonist Therapeutics announced its third quarter and nine-month 2025 earnings, reporting a net loss of US$39.34 million for the quarter and US$85.77 million for the nine-month period, both wider than the prior year. The nine-month period marks a dramatic financial swing from net income last year to a substantial net loss this year. We'll explore what Protagonist Therapeutics' wider losses mean for its investment narrative and long-term prospects. Rare earth metals are the new gold rush...

Concentrix (CNXC) is drawing investor attention after boosting its full-year adjusted free cash flow guidance and announcing a higher quarterly dividend. The company’s iX Hero platform has played a big part in recent client acquisitions, reflecting confidence in its AI-focused strategy. See our latest analysis for Concentrix. Concentrix shares have faced steep declines in recent months, with a 30-day share price return of -20.56% and a year-to-date drop of nearly 19%. Even so, after a tough...

Nordson (NDSN) shares have eased about 1% over the past week, with a slight dip also seen across the past month. Investors are watching these moves as the company’s fundamentals remain largely unchanged. See our latest analysis for Nordson. After a solid stretch earlier this year, Nordson’s momentum has cooled off a bit, with its 1-year total shareholder return currently negative despite a year-to-date share price gain of 12%. This serves as a reminder that short-term price bumps do not...